Posaconazole product-specific bioequivalence guidance

This document provides product-specific guidance on the demonstration of the bioequivalence of posaconazole gastro-resistant tablet 100 mg.

Keywords: Bioequivalence, generics, posaconazole

Abbreviations:

• BCS Classification: Biopharmaceutics Classification System
• AUC_0-t: area under the plasma concentration curve from administration to last observed concentration at time t
• AUC_0-72: area under the plasma concentration curve from administration to last observed concentration at 72 hours
• C_max: maximum plasma concentration

Current effective version

Posaconazole gastro-resistant tablet 100 mg product-specific bioequivalence guidance

AdoptedReference Number: EMA/CHMP/800785/2017Summary:

Posaconazole gastro-resistant tablet 100 mg product-specific bioequivalence guidance

Document history - First version

Posaconazole gastro-resistant tablet 100 mg product-specific bioequivalence guidance

AdoptedReference Number: EMA/CHMP/800785/2017Summary:

Posaconazole gastro-resistant tablet 100 mg product-specific bioequivalence guidance

Draft posaconazole gastro-resistant tablet 100 mg product-specific bioequivalence guidance

Draft: consultation closedConsultation dates: 31/01/2018 to 30/04/2018Reference Number: EMA/CHMP/800785/2017Summary:

Posaconazole gastro-resistant tablet 100 mg product-specific bioequivalence guidance